Corrigendum to “Ferroptosis in thyroid cancer: Potential mechanisms, effective therapeutic targets and predictive biomarker” [Biomed. Pharmacother. 177 (2024) 116971] - 04/02/25

Yuying Chen ^a, Gang Pan ^{b, ⁎}, Fan Wu ^b, Yu Zhang ^b, Yuanhui Li ^{b, ⁎} , Dingcun Luo ^{a, b, ⁎}

^a The Fourth Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou First Hangzhou People’s Hospital, Hangzhou, Zhejiang 310053, China 

^b Department of Surgical Oncology, Hangzhou First People’s Hospital, Westlake University School of Medicine, Hangzhou, Zhejiang 31006, China 

^⁎Corresponding author.^⁎⁎Corresponding author at: The Fourth Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou First Hangzhou People’s Hospital, Hangzhou, Zhejiang 310053, China.The Fourth Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou First Hangzhou People’s Hospital,HangzhouZhejiang310053China

Le texte complet de cet article est disponible en PDF.